Is One Shot of the HPV Vaccine Enough?
Research suggests that only one dose of the HPV vaccine may be effective enough to prevent HPV-related disease, including cancer.
Even More Evidence for the Value of Early HPV Vaccination
An exciting new study in Scotland found no cases of invasive cervical cancer in young women who had gotten the HPV vaccine by the time they were 14. The study also found that women vaccinated between ages 14 and 22 had lower rates of cervical cancer than unvaccinated women.
Scotland began a vaccination program in 2008. It offered the HPV vaccine to girls in their first year of secondary school (ages 12 or 13). To determine how effective the vaccine was, researchers analyzed health records for all young women born between 1988 and 1996.
The results show that the vaccination was 100% effective against cervical cancer when given at ages 12 or 13, 86% effective when given between ages 14 and 16, and 39% effective when given at ages 17 or 18. The study found no protective benefits when the vaccine was given over the age of 18.
It is important to note that many women who were vaccinated as part of this program are in their 20s and 30s now, which is still quite young. The average age for diagnosis of cervical cancer in the United States, for example, is 50. To truly understand the protection provided by the vaccine, researchers will need to continue following young people who’ve gotten the shot into their 60s and 70s.
In addition, the women in this study received a bivalent version of the HPV vaccine. It protected against HPV types 16 and 18 which are known to cause most cervical cancers, as well as other types known to cause genital warts. Today, both the U.K. and the U.S. use a nonavalent vaccine. It protects against nine types of HPV known to cause cervical and other cancers such as anal, vulvar/vaginal, and oropharyngeal cancers (those of the head and neck). Again, to truly understand the protection provided by the vaccine, we will need to follow people given this newer version of the vaccine for several decades as well.
Still, this study offers more proof that vaccinating young people early provides the best protection against cervical cancer. It also confirmed that younger people (12 and 13) need fewer shots (one or two) to be fully protected while people starting later should get three shots.
The HPV vaccine is recommended for people of all sexes and genders between ages 9 and 26 though it can be given up to age 45. The CDC recommends that the HPV vaccine be part of the routine vaccinations given to young people at ages 11 or 12.
Experts in the U.S. have said that we can eliminate cervical cancer in this country with widespread HPV vaccination.
More to explore
HPV Vaccination and Screening Help Australia Get Closer to Eliminating Cervical Cancer
Australia has been a leader in HPV-prevention and cervical cancer screening for decades. Because of this, it is now close to eliminating cervical cancer entirely. However, recent drops in vaccination and screening rates threaten this progress.
ACS Releases New Cervical Cancer Screening Guidelines
The American Cancer Society (ACS) released new recommendations for cervical cancer screening that focus on HPV testing and approve the use of self-collected samples. The recommendations also clarify the age at which screening should start and stop.
Study Shows Herd Immunity for HPV is Possible
We’ve known for years that the HPV vaccine works. Now new research shows that widespread vaccination even protects those who haven’t gotten the shot. This study proves that it is possible to reach herd immunity for HPV.
HPV and Relationships
HPV is one of the most common sexually transmitted infections. Still, finding out that you or your partner has it can feel stressful and confusing. It’s normal to have a lot of questions: What does this mean for our health? Did someone cheat? Should we
FDA Approves At-Home Collection Device for Cervical Cancer Screening
The FDA just approved the Teal Wand, a self-collection device for HPV testing that does not require a speculum exam or even a trip to the doctor’s office. People can collect their own sample at home and send it to a lab for analysis.
One and Done? New Study Suggests that One Dose of HPV Vaccine May Be Enough
The results of large-scale study of HPV suggest that one shot of the vaccine may be enough to protect young people from HPV and related issues like cervical cancer.
HPV-Related Head and Neck Cancer
You have probably heard that HPV can cause cervical cancer. But did you know that it can also cause cancers of the mouth, tongue, and throat?